SCHEMBL21362429

SCHEMBL21362429

C=C(c1ccc(CBr)cc1Br)c1ccc(F)cc1OC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
MAPT P10636 2/20 0.40
ALDH1A1 P00352 2/20 0.38
USP2 O75604 1/20 0.38
GAA P10253 1/20 0.38
ALOX15 P16050 1/20 0.38
ALOX12 P18054 1/20 0.38
HSD17B10 Q99714 1/20 0.38
FFAR4 Q5NUL3 3/20 0.36
FFAR1 O14842 2/20 0.36
HTR2A P28223 2/20 0.36
NR3C1 P04150 1/20 0.35
PTPN7 P35236 1/20 0.34
DUSP3 P51452 1/20 0.34
APLNR P35414 1/20 0.34
PYGL P06737 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20157512 0.85 NPC1 (0.46) SMN1; SMN2NPC1RAB9AKMT2AMEN1
SCHEMBL20158037 0.81 HTT (0.43) RAB9AKMT2AMEN1MAPTALDH1A1
SCHEMBL20157513 0.75 NPC1 (0.46) SMN1; SMN2NPC1RAB9AKMT2AMEN1
SCHEMBL20157850 0.71 MAPT (0.39) SMN1; SMN2NPC1RAB9AKMT2AMEN1
SCHEMBL21252887 0.71 NPC1 (0.42) SMN1; SMN2NPC1RAB9AKMT2AMEN1
SCHEMBL29463290 0.70 MAPT (0.56) SMN1; SMN2KMT2AMEN1MAPTALDH1A1
SCHEMBL333582 0.70 MAPT (0.56) SMN1; SMN2KMT2AMEN1MAPTALDH1A1
SCHEMBL20158023 0.70 ABL1 (0.45) SMN1; SMN2NPC1RAB9AKMT2AMEN1
SCHEMBL5286155 0.70 NPC1 (0.42) SMN1; SMN2NPC1RAB9AALDH1A1FFAR4
SCHEMBL20158025 0.70 NPC1 (0.42) SMN1; SMN2NPC1RAB9AKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3539960-A1 NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF Luoxin Pharmaceutical (Shanghai) Co., Ltd. (CN) 2019-09-18 EP disclosed